Articles related to Rheumatology

“The increased risk of NAION with Wegovy is due to the higher dosage of semaglutide…the difference between the two dosages and the rates of NAION may indicate a dose-dependent increase in risk.” – Benjamin Bert, MD

“These findings support the role of OCTA as an adjunctive tool for monitoring [hydroxychloroquine-induced] retinal changes, while further longitudinal studies are needed to clarify its predictive value.” – Study authors

Early treatment phases may transiently promote immune activation, whereas sustained therapy, by reducing BMI and lowering systemic inflammation, may mitigate this effect.

Although most studies indicated a positive trend of yogurt intake on bone health, the evidence was insufficient to support that yogurt intake helps in BMD improvements or fracture prevention in adults.

“The data on leucovorin isn’t very strong… At best it can be mildly beneficial in some patients with autism. It’s not going to cure it. It’s just going to cause a massive headache for rheumatologists since they actually need to prescribe leucovorin to people with RA on methotrexate who can’t tolerate folic acid.” —Family medicine physician

“Living with mysterious symptoms while being dismissed is one of the most isolating experiences you can go through… On the outside, I looked fine. Inside, I was barely surviving.” – Erika Schlick, Health Coach & Wellness Advocate